Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer. - Abhang K; Dighe S; Katari O; Yadav V; Jain S (Drug delivery and translational research, 2025)